Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Hum Exp Toxicol ; 35(12): 1243-1251, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26801985

RESUMO

Intestinal mucositis is a serious toxic side effect of 5-fluorouracil (5-FU) treatment. Bu-Zhong-Yi-Qi decoction (BZYQD), a water extract of Chinese traditional herbal medicine, is widely used in chemotherapy in Asia as an alternative treatment to reduce the side effects of chemotherapy. However, the mechanism is unknown. To evaluate its mechanism, we investigated the effect of BZYQD on 5-FU-induced intestinal mucositis in mice, especially with regard to apoptosis in the intestinal mucosal epithelia. In the present study, mice were divided into three groups: control, 5-FU, and 5-FU + BZYQD. Mice in the 5-FU and 5-FU + BZYQD groups were administered 5-FU (100 mg/kg/day, intraperitoneally) for 6 days, and the mice in the latter group were given BZYQD (8 g/kg/day, intragastrically) beginning 4 days before 5-FU and continuing until the termination of the experiment. Loss in body weight and diarrhea during the 5-FU treatment were significantly attenuated by administration of BZYQD. The morphological signs of intestinal damage, including shortened villi height, crypt destruction, apoptosis, and necrosis, in intestinal mucosal epithelia were also reversed, accompanied by reduced neutrophil infiltration, nitrite levels, and inflammatory factors (tumor necrosis factor α and interleukin 1ß) and increased levels of reduced glutathione. These results suggest that BZYQD inhibits 5-FU-induced intestinal mucositis, and this effect may be due to the reduction in apoptosis and necrosis in intestinal mucosal epithelia via the suppression of inflammatory cytokine upregulation. In conclusion, inhibiting cytokine-mediated apoptosis or necrosis can be the molecular mechanism by which BZYQD reduces the gastrointestinal side effects of cancer chemotherapy.


Assuntos
Anti-Inflamatórios/uso terapêutico , Antimetabólitos Antineoplásicos/toxicidade , Medicamentos de Ervas Chinesas/uso terapêutico , Fluoruracila/toxicidade , Mucosa Intestinal/efeitos dos fármacos , Mucosite/prevenção & controle , Animais , Anti-Inflamatórios/administração & dosagem , Apoptose/efeitos dos fármacos , Apoptose/imunologia , Citocinas/metabolismo , Medicamentos de Ervas Chinesas/administração & dosagem , Mucosa Intestinal/imunologia , Mucosa Intestinal/ultraestrutura , Jejuno/efeitos dos fármacos , Jejuno/imunologia , Jejuno/ultraestrutura , Camundongos Endogâmicos , Microscopia Eletrônica de Transmissão , Mucosite/induzido quimicamente , Mucosite/tratamento farmacológico , Mucosite/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA